Talia Kaden, MD - Considerations for Identifying the Right Patient for Intravitreal Anti-VEGF Injections in nAMD CME in Minutes: Education in Ophthalmology

Please visit answersincme.com/HEQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses how to optimize the use of intravitreal anti-vascular endothelial growth factor (VEGF) therapies in patients with neovascular age-related macular degeneration (nAMD) using a case-based approach with perspectives from a patient. Upon completion of this activity, participants should be better able to: Describe the latest evidence for anti-VEGF therapies used in the treatment of nAMD; Outline practical strategies to optimize the use of anti-VEGF therapies in the management of nAMD; and Explain the importance of shared decision-making in the management of nAMD.